CDH1 and urinary bladder cancer: Similarly, our results echo those of Xie et al. [19], who demonstrated a significant correlation between decreased E-cadherin expression and both advanced pathological T stage and higher tumor grade in bladder cancer. This suggests a potential role for E-cadherin as a marker of tumor aggressiveness and progression.